Kristen Bowlds

Kristen Bowlds

Board Member

Kristen Bowlds has a passion for marketing. A young leader at C.H. Robinson working in market research and industry marketing, her focus abruptly shifted following the birth of her second child as she experienced multiple heart attacks due to Spontaneous Coronary Artery Dissection (SCAD). After her diagnosis, Kristen has worked hand in hand with MHIF to raise awareness and generate research funds to make a difference.  

Her advocacy forums include the first-ever Minnesota 5K SCADaddle run for research, NBC’s the Today Show,  ABC News Live, and multiple local television and radio network specials that put heart health at the forefront. She brings a wealth of marketing knowledge, a passion for heart health, and a unique personal perspective to MHIF.

Kristen has a Marketing & Management degree from Iowa State University and lives in Chanhassen with her husband and two young children.  

Back to Board of Directors

Kristen Bowlds
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.